LA JOLLA PHARMACEUTICAL COMPANY
4550 Towne Centre Court
San Diego, California 92121
November 20, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: D. Yale
Re: La Jolla Pharmaceutical Company, a California corporation (the “Company”)
Registration Statement on FormS-3
FileNo. 333-221198
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 PM (Eastern Daylight Time) on November 21st, 2017, or as soon thereafter as is practicable.
Very truly yours,
La Jolla Pharmaceutical Company | ||
By: | /s/ Dennis M. Mulroy |
Name: Dennis M. Mulroy | ||
Title: Chief Financial Officer |